AlphAIalphai — Financial news for AI agents
stocktitan.netAUG 261 min read$AMRZ

Amrize (AMRZ) legal chief lifts stake to 7,500 shares total

Amrize Ltd (AMRZ) reported that its Chief Legal Officer, Denise R. Singleton, purchased 3,500 shares at $44.115 each on 2026-08-25, bringing her total holding to 7,500 shares. The transaction was not under a Rule 10b5-1 plan.

Original reporting
stocktitan.net
Published Aug 26, 2026, 2:57 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 8:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$AMRZ
Bullish
medium confidence
Mentioned
$AMRZ
Relevance
6/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$AMRZBullishLow
01

Why it matters

The purchase adds modest confidence but unlikely to move price materially.

02

Market read

Micro‑cap insider buying; limited trading relevance.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 6/10Novelty 6/10Timing: post‑market 2026‑08‑25

Background

Form 4 filing reports insider transaction for Amrize Ltd.

Company-level read

Ticker impact

$AMRZBullishMedium confidence
Context

Chief Legal Officer Denise R. Singleton purchased 3,500 shares at $44.115, raising her holding to 7,500 shares.

Expected impact

Potential slight price uptick in short term.

Evidence & confidence

Purchase size is modest relative to market cap; no 10b5‑1 plan indicated.

Market effects

Sector

None significant; insider activity limited to company level.

Regional

Minimal, confined to Amrize shareholders.

Global

Low; micro‑cap event with limited broader impact.

Counterpoint

What could challenge this read

Insider purchase could be routine compensation, not a strong bullish signal.

Key entities

  • person
    Denise R. Singleton

    Chief Legal Officer & Corporate Secretary of Amrize Ltd.

  • company
    Amrize Ltd

    Issuer of the shares purchased.

Read at source← All news

Related articles

AUG 14
$AMRZMedAI 8/10

Amrize (AMRZ) Q2 2026 Earnings Call Transcript

Amrize AG (AMRZ) reported Q2 2026 revenue of $3.49B, up 8.6%, and net income of $476M, up 14.4%, with adjusted EBITDA of $986M. Management raised fiscal 2026 revenue guidance to $12.5B-$12.7B but revised adjusted EBITDA to $3.1B-$3.2B due to oil-driven cost inflation. The company cited data center and infrastructure demand.

fool.com6 min
AUG 10
$AMRZMedAI 8/10

Amrize Q2 EPS misses $0.94 estimate as costs weigh on margins

Amrize (NYSE: AMRZ) reported Q2 2026 adjusted EPS of $0.88, below the $0.94 consensus estimate. Revenue rose 8.51% to $3.494 billion, beating the $3.365 billion expectation. Net income increased 14.4% to $476 million. The company raised FY2026 revenue guidance to $12.5B-$12.7B but lowered adjusted EBITDA guidance to $3.1B-$3.2B due to cost inflation.

scanx.trade6 min
AUG 10
$AMRZMed

RBC Downgrades Amrize After A Rare Q2 Miss

RBC downgraded Amrize after a rare Q2 miss and reduced guidance, citing a timing mismatch between input-cost increases and the full pass-through of surcharges and price hikes. RBC cut 2026-2028 EBITDA estimates by 4%, 6%, and 7% and EPS by 12%, 14%, and 15%, lowering its stock rating to underperform and price target to $48 from $60.

finimize.com4 min